Support for this proposal comes from studies of animal models of anti-GBM glomerulonephritis and Alport's syndrome in which prominent tubular JNK activation develops secondary to glomerular injury (Ma et al., 2009; Nakagawa et al., 2016). This evidence concerns the gene MAPK8 and glomerulonephritis.